The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

Jan 14, 2023 -- A vaccine database found a possible link between the Pfizer/BioNTech bivalent COVID-19 vaccine and ischemic strokes in people over 65 who got the shot, the CDC and the FDA said in ...

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

Once adopted by the FDA and Centers for Disease Control and Prevention, the change could effectively end use of the original ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The U.S. Food and Drug Administration vaccine advisory panel on Thursday voted unanimously to recommend that the agency phase ...

The CDC and FDA announced on Friday that their surveillance system flagged a possible link between the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over ...

The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine.

A panel of independent experts that advises the Food and Drug Administration on vaccines has backed a proposal to use the ...

At a meeting of this FDA ... Covid-19 and who did not. It found that 1.9% of the study participants who received the original booster became infected. Among those who got the updated bivalent ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...